3.01

3.01 (-1.44%)

As of Mar 06, 2024

LUMOS PHARMA, INC. [LUMO]

Source: 

Company Overview

We have focused our efforts on the development of our sole product candidate, growth hormone secretagogue ibutamoren (“LUM-201”), a potential oral therapy for pediatric growth hormone deficiency (“PGHD”) and other rare endocrine disorders.

CountryUS
Headquartersaustintexas
Phone Number(512) 215-2630
Industrypharmaceutical preparations
CEORichard J. Hawkins
Websitewww.lumos-pharma.com.